Leukemia

  1. Besponsa (inotuzumab ozogamicin)
    Besponsa (inotuzumab ozogamicin)
    by Pfizer Limited
    for Leukemia
    €16,847.50
  2. Blincyto (blinatumomab)
    Blincyto (blinatumomab)
    by Amgen
    for Leukemia
    €3,047.50
  3. Rydapt (midostaurin)
    Rydapt (midostaurin)
    by Novartis Europharm Limited
    for Leukemia
    €10,830.70
  4. Venclyxto/Venclexta (venetoclax)
    Venclyxto/Venclexta (venetoclax)
    by AbbVie Ltd
    for Leukemia
    €180.00
View as Grid List

4 Items

per page
Set Descending Direction

Just one thing before you continue

Our service contains information about acquiring treatments that have been approved in another country. This includes professional information such as approval details, product information and pricing. By scrolling, you are declaring that you are requesting any such information.

No, take me out of here.
CONTINUE